ArticleJournal of experimental & clinical cancer research : CR2018

FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma.

Bo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.